Artelo Biosciences Inc (NAS:ARTL)
$ 1.1152 -0.004 (-0.36%) Market Cap: 3.60 Mil Enterprise Value: -1.88 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 37/100

Artelo Biosciences Inc at MicroCap Rodeo: Spring Into Action -- Best Ideas Virtual Investor Conference (Virtual) Transcript

May 16, 2022 / 06:00PM GMT
Release Date Price: $4.82 (-2.69%)
Unidentified Participant

Welcome to the Spring into Action Best Ideas Virtual Investor Conference. The next presenting company is Artelo Biosciences, Inc. (Operator Instructions)

I'd now like to turn the floor over to today's host, Gregory Gorgas, President and CEO of Artelo Biosciences. Sir, the floor is yours.

Gregory Gorgas
Artelo Biosciences, Inc. - President and CEO

Thank you very much, Matt, and thank you very much for all the investors that are back with us at the MicroCap Rodeo Spring into Action. It's great to be back with you. As was introduced, I'm Greg Gorgas. I'm the founding CEO at Artelo Biosciences. We're on the NASDAQ under the symbol ARTL.

I will be making some forward-looking statements today. We would ask all investors to go to our website, artelobio.com, where all of our filings are linked and are current.

Today, we're going to cover five main topics, five main topics to introduce Artelo. Now some of you are new to the story and some of you are experienced with Artelo. And I'm going to try and aim to share about Artelo

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot